Vanguard Group’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.8M | Sell |
7,611,499
-253,882
| -3% | -$693K | ﹤0.01% | 2537 |
|
|
2025
Q1 | $13.2M | Sell |
7,865,381
-2,882,379
| -27% | -$4.84M | ﹤0.01% | 2695 |
|
|
2024
Q4 | $17.5M | Sell |
10,747,760
-2,435,792
| -18% | -$3.97M | ﹤0.01% | 2645 |
|
|
2024
Q3 | $54.8M | Buy |
13,183,552
+304,872
| +2% | +$1.27M | ﹤0.01% | 2136 |
|
|
2024
Q2 | $70.3M | Buy |
12,878,680
+723,507
| +6% | +$3.95M | ﹤0.01% | 2009 |
|
|
2024
Q1 | $122M | Buy |
12,155,173
+2,358,089
| +24% | +$23.6M | ﹤0.01% | 1764 |
|
|
2023
Q4 | $40M | Buy |
9,797,084
+629,499
| +7% | +$2.57M | ﹤0.01% | 2282 |
|
|
2023
Q3 | $35.5M | Buy |
9,167,585
+107,167
| +1% | +$415K | ﹤0.01% | 2293 |
|
|
2023
Q2 | $54M | Sell |
9,060,418
-25,514
| -0.3% | -$152K | ﹤0.01% | 2148 |
|
|
2023
Q1 | $29.7M | Buy |
9,085,932
+119,297
| +1% | +$390K | ﹤0.01% | 2417 |
|
|
2022
Q4 | $35.4M | Buy |
8,966,635
+126,754
| +1% | +$501K | ﹤0.01% | 2339 |
|
|
2022
Q3 | $53M | Buy |
8,839,881
+787,470
| +10% | +$4.72M | ﹤0.01% | 2152 |
|
|
2022
Q2 | $51.8M | Buy |
8,052,411
+382,729
| +5% | +$2.46M | ﹤0.01% | 2177 |
|
|
2022
Q1 | $63.4M | Sell |
7,669,682
-38,469
| -0.5% | -$318K | ﹤0.01% | 2186 |
|
|
2021
Q4 | $119M | Buy |
7,708,151
+119,607
| +2% | +$1.85M | ﹤0.01% | 1894 |
|
|
2021
Q3 | $171M | Buy |
7,588,544
+5,127,363
| +208% | +$115M | ﹤0.01% | 1696 |
|
|
2021
Q2 | $48.4M | Buy |
2,461,181
+133,574
| +6% | +$2.63M | ﹤0.01% | 2393 |
|
|
2021
Q1 | $77.9M | Buy |
+2,327,607
| New | +$77.9M | ﹤0.01% | 2085 |
|